Bullboard - Stock Discussion Forum Anavex Life Sciences Corp AVXL

Healthcare Biotechnology

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more

Add To Watchlist

NDAQ:AVXL - Post Discussion

Anavex Life Sciences Corp > End of Month - July 2020

View:

Post by R_J_ on Aug 02, 2020 5:01am

End of Month - July 2020

End of the Month (EOM) report for July 2020 for Anavex Life Sciences Corp.
-
AVXL closed on 07/31/2020 at US$4.22
AVXL closed on 06/30/2020 at US$4.92
-
This is a 14.2%, a 70-cent, Loss for July.
-
S&P 500 Index, @ 3271.1 gained 5.5% in July. [7.3% above its MA(200) @ 3048.6]
-
Two Hundred Day Moving Average [MA(200)] stuff.
AVXL's MA(200) ended July at $3.45
AVXL is now 22.3% above its MA(200).
-
News Releases on the AVXL Website in July
-
Use this link to see and read the all of July’s News Releases.
-
https://www.anavex.com/2020/07/
-
Who is the Big Cheese at AVXL?
Christopher U. Missling, PhD, President & CEO
-
RJ

235